Detalles de la búsqueda
1.
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.
Cancer Immunol Immunother;
72(7): 2099-2111, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36823323
2.
Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy.
bioRxiv;
2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36896021
3.
Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen-specific inhibition of human cell-mediated lympholysis.
J Exp Med;
142(6): 1339-48, 1975 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-53262
4.
Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.
J Exp Med;
176(2): 531-41, 1992 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-1500859
5.
Pre-emption of human cell-mediated lympholysis by a suppressive mechanism activated in mixed lymphocyte cultures.
J Exp Med;
142(6): 1606-11, 1975 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-127827
6.
Responsiveness of germfree mice in mixed leukocyte culture. Reexamining the nature of the responding unit.
J Exp Med;
136(2): 398-402, 1972 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-5065082
7.
Three HLA-D region antigens defined by primed LD typing.
J Exp Med;
144(2): 549-54, 1976 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-134127
8.
Secondary cell-mediated lympholysis: importance of H-2 LD and SD factors.
J Exp Med;
143(5): 1005-14, 1976 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-131173
9.
Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.
J Exp Med;
172(4): 1101-14, 1990 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-1698909
10.
Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis.
J Exp Med;
171(5): 1567-79, 1990 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-2185329
11.
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes.
Science;
188(4195): 1308-10, 1975 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-124948
12.
Cell mediated immunity: separation of cells involved in recognitive and destructive phases.
Science;
180(4084): 403-6, 1973 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-4267047
13.
HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
J Clin Invest;
71(6): 1779-86, 1983 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-6223050
14.
A human T cell clone that mediates the monocyte procoagulant response to specific sensitizing antigen.
J Clin Invest;
76(3): 1279-82, 1985 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-2413073
15.
Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin.
J Natl Cancer Inst;
80(18): 1451-61, 1988 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-3263508
16.
Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity.
J Natl Cancer Inst;
80(1): 60-3, 1988 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-3257526
17.
Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
Cancer Res;
49(13): 3680-8, 1989 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-2471587
18.
In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2.
Cancer Res;
48(7): 1965-71, 1988 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-3258180
19.
Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.
Cancer Res;
48(9): 2561-7, 1988 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-3258545
20.
In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
Cancer Res;
46(10): 5413-8, 1986 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-3530439